Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are suspected of having lung cancer or a lung nodule, stomach cancer or a stomach lesion, or colorectal cancer or a colorectal lesion
- People who have signed a consent form agreeing to take part in the trial
- People who have detailed medical records available, including imaging records, pathology reports, genetic or biological test results, and other important diagnostic information
- Healthy people who have not been diagnosed with lung cancer or a lung nodule, stomach cancer or a stomach lesion, or colorectal cancer or a colorectal lesion
Who may not be able to join:
- People whose key medical or pathology records are missing or incomplete
- People who are unable to be contacted for follow-up appointments or check-ins during the trial
- People whose medical scan images are of too low a quality for the trial team to accurately analyse and mark the areas of interest
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 15107177084
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The outcome of clinical diagnosis of suspected patients with lung cancer/pulmonary nodular (Benign/Malignant nodule); The outcome of clinical diagnosis of suspected patients with stomach cancer or lesion (Benign/Malignant).; The outcome of clinical diagnosis of suspected patients with colorectal cancer or lesion (Benign/Malignant).; Treatment response of anti-cancer therapy at first evaluation in patients with lung/stomach/colorectal cancer (CR, PR, PD, SD).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.